Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Ephrin B1 ELISA Kit (AC2574)
Cat.#: ASET-1163
Specifications
Description Human Ephrin B1 ELISA Kit allows for the in vitro quantitative determination of human Ephrin B1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-1335 Human Neurocan ELISA Kit (AC2746) Quantitative inquiry ASET-1052 Human PDE6B ELISA Kit (AC2463) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry ASET-1263 Human GPR37L1 ELISA Kit (AC2674) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-1313 Mouse beta III Tubulin ELISA Kit (AC2724) Quantitative inquiry ASET-1103 Mouse LC3B ELISA Kit (AC2514) Quantitative inquiry ASET-1424 Human Semaphorin 3F ELISA Kit (AC2835) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket